Literature DB >> 32198314

11C-PABA as a PET Radiotracer for Functional Renal Imaging: Preclinical and First-in-Human Study.

Camilo A Ruiz-Bedoya1,2, Alvaro A Ordonez1,2, Rudolf A Werner3, Donika Plyku4, Mariah H Klunk1,2, Jeff Leal4, Wojciech G Lesniak4, Daniel P Holt4, Robert F Dannals4, Takahiro Higuchi5,6, Steven P Rowe4, Sanjay K Jain7,2,4.   

Abstract

para-Aminobenzoic acid (PABA) has been previously used as an exogenous marker to verify completion of 24-h urine sampling. Therefore, we hypothesized that PABA radiolabeled with 11C might allow high-quality dynamic PET of the kidneys with less radiation exposure than other agents because of its shorter biologic and physical half-life. We evaluated if 11C-PABA can visualize renal anatomy and quantify function in healthy rats and rabbits and in a first-in-humans study on healthy volunteers.
Methods: Healthy rats and rabbits were injected with 11C-PABA intravenously. Subsequently, dynamic PET was performed, followed by postmortem tissue-biodistribution studies. 11C-PABA PET was directly compared with the current standard, 99mTc-mercaptoacetyltriglycin, in rats. Three healthy human subjects also underwent dynamic PET after intravenous injection of 11C-PABA.
Results: In healthy rats and rabbits, dynamic PET demonstrated a rapid accumulation of 11C-PABA in the renal cortex, followed by rapid excretion through the pelvicalyceal system. In humans, 11C-PABA PET was safe and well tolerated. There were no adverse or clinically detectable pharmacologic effects in any subject. The cortex was delineated on PET, and the activity gradually transited to the medulla and then pelvis with high spatiotemporal resolution.
Conclusion: 11C-PABA demonstrated fast renal excretion with a very low background signal in animals and humans. These results suggest that 11C-PABA might be used as a novel radiotracer for functional renal imaging, providing high-quality spatiotemporal images with low radiation exposure.
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  PABA; PET; renal imaging; renography; translational science

Mesh:

Substances:

Year:  2020        PMID: 32198314      PMCID: PMC9364887          DOI: 10.2967/jnumed.119.239806

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   11.082


  30 in total

1.  Studies on the metabolism of para-aminobenzoic acid.

Authors:  C W TABOR; M V FREEMAN; J BAILY; P K SMITH
Journal:  J Pharmacol Exp Ther       Date:  1951-06       Impact factor: 4.030

2.  A Systematic Approach for Developing Bacteria-Specific Imaging Tracers.

Authors:  Alvaro A Ordonez; Edward A Weinstein; Lauren E Bambarger; Vikram Saini; Yong S Chang; Vincent P DeMarco; Mariah H Klunk; Michael E Urbanowski; Kimberly L Moulton; Allison M Murawski; Supriya Pokkali; Alvin S Kalinda; Sanjay K Jain
Journal:  J Nucl Med       Date:  2016-09-15       Impact factor: 10.057

3.  The SNMMI and EANM practice guideline for renal scintigraphy in adults.

Authors:  M Donald Blaufox; Diego De Palma; Andrew Taylor; Zsolt Szabo; Alain Prigent; Martin Samal; Yi Li; Andrea Santos; Giorgio Testanera; Mark Tulchinsky
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-30       Impact factor: 9.236

4.  Novel Functional Renal PET Imaging With 18F-FDS in Human Subjects.

Authors:  Rudolf A Werner; Alvaro A Ordonez; Julian Sanchez-Bautista; Charles Marcus; Constantin Lapa; Steven P Rowe; Martin G Pomper; Jeffrey P Leal; Martin A Lodge; Mehrbod S Javadi; Sanjay K Jain; Takahiro Higuchi
Journal:  Clin Nucl Med       Date:  2019-05       Impact factor: 7.794

5.  Imaging effects of radiation therapy in the abdomen and pelvis: evaluating "innocent bystander" tissues.

Authors:  Katherine E Maturen; Mary U Feng; Ashish P Wasnik; Shadi F Azar; Henry D Appelman; Isaac R Francis; Joel F Platt
Journal:  Radiographics       Date:  2013 Mar-Apr       Impact factor: 5.333

6.  Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent.

Authors:  Hiroshi Wakabayashi; Rudolf A Werner; Nobuyuki Hayakawa; Mehrbod S Javadi; Chen Xinyu; Ken Herrmann; Steven P Rowe; Constantin Lapa; Takahiro Higuchi
Journal:  J Nucl Med       Date:  2016-03-24       Impact factor: 10.057

7.  RADAR realistic animal model series for dose assessment.

Authors:  Mary A Keenan; Michael G Stabin; William P Segars; Michael J Fernald
Journal:  J Nucl Med       Date:  2010-03       Impact factor: 10.057

8.  Radiosynthesis and validation of [Carboxy-11 C]4-Aminobenzoic acid ([11 C]PABA), a PET radiotracer for imaging bacterial infections.

Authors:  Daniel P Holt; Alvin S Kalinda; Lauren E Bambarger; Sanjay K Jain; Robert F Dannals
Journal:  J Labelled Comp Radiopharm       Date:  2018-08-29       Impact factor: 1.921

9.  [11C]Para-Aminobenzoic Acid: A Positron Emission Tomography Tracer Targeting Bacteria-Specific Metabolism.

Authors:  Christopher A Mutch; Alvaro A Ordonez; Hecong Qin; Matthew Parker; Lauren E Bambarger; Javier E Villanueva-Meyer; Joseph Blecha; Valerie Carroll; Celine Taglang; Robert Flavell; Renuka Sriram; Henry VanBrocklin; Oren Rosenberg; Michael A Ohliger; Sanjay K Jain; Kiel D Neumann; David M Wilson
Journal:  ACS Infect Dis       Date:  2018-05-08       Impact factor: 5.084

10.  Positron Emission Tomography Imaging with 2-[18F]F- p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug Response.

Authors:  Zhuo Zhang; Alvaro A Ordonez; Hui Wang; Yong Li; Kayla R Gogarty; Edward A Weinstein; Fereidoon Daryaee; Jonathan Merino; Grace E Yoon; Alvin S Kalinda; Ronnie C Mease; James N Iuliano; Peter M Smith-Jones; Sanjay K Jain; Peter J Tonge
Journal:  ACS Infect Dis       Date:  2018-08-17       Impact factor: 5.084

View more
  1 in total

1.  11C-Para-aminobenzoic acid PET imaging of S. aureus and MRSA infection in preclinical models and humans.

Authors:  Alvaro A Ordonez; Matthew Fl Parker; Robert J Miller; Donika Plyku; Camilo A Ruiz-Bedoya; Elizabeth W Tucker; Justin M Luu; Dustin A Dikeman; Wojciech G Lesniak; Daniel P Holt; Robert F Dannals; Lloyd S Miller; Steven P Rowe; David M Wilson; Sanjay K Jain
Journal:  JCI Insight       Date:  2022-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.